Abbott aims to revive cyclamate sweetener in U.S. market
Abbott Laboratories plans to file a formal petition to resume marketing cyclamate, arguing new global studies show safety and that the FDA will review data impartially. If approved, cyclamate sweetened products could return to American supermarkets as early as next summer, restoring a once popular sugar substitute.
MENTIONED IN THIS ARTICLE
Barbara Gibbons
Abbott Laboratories
Thomas Craig
Abbott
Federal Food and Drug Administration
FDA
Craig
America
France
Germany
Switzerland
National Academy of Sciences
Heidelberg
German Cancer Research Center
U.S
National Cancer Institute
Bio-Research Consultants Labs
Cambridge
Mass
Wisconsin Alumni Research Foundation
WARF
Abbott Labs
Also Mentioned on This Page
Slim Gourmet
Moistu
Rotio
Bonne Bell
Howland
Bonne
Jane
Sia
Middletown, N.Y
Route
Middletown
Union Ave
Newburgh